NEXTGEN HEALTHCARE, INC (NXGN)
(Delayed Data from NSDQ)
$19.75 USD
+0.51 (2.65%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.76 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.75 USD
+0.51 (2.65%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.76 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Wall Street Analysts Predict a 25% Upside in Nextgen Healthcare (NXGN): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in Nextgen Healthcare (NXGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why You Should Hold on to Integra (IART) Stock for Now
by Zacks Equity Research
Investors are optimistic about Integra (IART) given its better-than-expected results and robust performance of the CSS arm in the third quarter.
Allscripts' (MDRX) Services Leveraged by Next Level Urgent Care
by Zacks Equity Research
Allscripts' (MDRX) Touchworks platform and Microsoft Azure hosting & services will be implemented across all Next Level Urgent Care's sites in Houston.
Here's Why You Should Hold on to Syneos Health (SYNH) for Now
by Zacks Equity Research
Investors about optimistic about Syneos Health (SYNH) given its better-than-expected results as well as strong segmental performance during the third quarter.
Here's Why You Should Add Omnicell (OMCL) To Your Portfolio
by Zacks Equity Research
Investors are optimistic about Omnicell (OMCL) owing to its better-than-expected results in the third quarter and robust segmental performance.
Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots
by Zacks Equity Research
Individuals aged 18 years or older are eligible to avail Pfizer, Moderna or Johnson & Johnson COVID-19 vaccine boosters from Walgreens' (WBA) stores.
NXGN vs. OMCL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NXGN vs. OMCL: Which Stock Is the Better Value Option?
Nextgen Healthcare (NXGN) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Nextgen Healthcare (NXGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NXGN or OMCL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NXGN vs. OMCL: Which Stock Is the Better Value Option?
Can Nextgen Healthcare (NXGN) Climb 27% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in Nextgen Healthcare (NXGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NextGen Healthcare (NXGN) Gains 9.7% Since Q2 Earnings Beat
by Zacks Equity Research
NextGen Healthcare's (NXGN) fiscal second-quarter earnings reflect strong segmental performance.
Nextgen Healthcare (NXGN) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 26.09% and 4.13%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Nextgen Healthcare (NXGN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Nextgen Healthcare (NXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NextGen's (NXGN) Integrated Platform Gets Leveraged by Mednax
by Zacks Equity Research
Mednax utilizes NextGen's (NXGN) fully-integrated platform to enhance its efficacy in placing crucial information on patients' health and well-being at the physician's fingertips.
Cerner's (CERN) Latest Offering to Improve RCM Portfolio
by Zacks Equity Research
Cerner's (CERN) latest offering is likely to streamline and automate revenue cycle via interoperability and enhanced usability.
Allscripts (MDRX), CareMetx Tie Up for Better Patient Care
by Zacks Equity Research
Allscripts' (MDRX) Veradigm enters collaboration with CareMetx to streamline specialty medication management for medical clinics and practices across the nation.
Here's Why You Should Hold on to NextGen (NXGN) Stock Now
by Zacks Equity Research
NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR. However, intense competition woes linger.
NextGen's (NXGN) New Partnership to Boost Patient Experience
by Zacks Equity Research
NextGen (NXGN) collaborates with Clinect Healthcare to extend patient-provider connection.
NextGen's (NXGN) New Collaboration to Boost Solutions Portfolio
by Zacks Equity Research
NextGen (NXGN) and Klamath partner to deliver large-scale COVID-19 vaccinations.
NextGen's (NXGN) RCM Services Adopted by Coastal Orthopedics
by Zacks Equity Research
NextGen's (NXGN) RCM Services aids Coastal Orthopedics to maintain its financial stability throughout the pandemic period.
NextGen (NXGN) Reaches 2 Million Telehealth Visit Milestone
by Zacks Equity Research
NextGen (NXGN) reaches a milestone by facilitating 2 million telehealth visits with the NextGen Virtual Visits platform since March 2020.
NextGen's (NXGN) Solutions to Boost Care for Homeless Community
by Zacks Equity Research
NextGen's (NXXGN) solutions collaborate with Neighborhood Health to provide care to Nashville's homeless community through the latter's street medicine program.
Here's Why You Should Hold on to NextGen (NXGN) Stock Now
by Zacks Equity Research
NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR. However, intense competition woes linger.
NextGen Healthcare (NXGN) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
NextGen Healthcare's (NXGN) fiscal first-quarter earnings reflect strong segmental performance.
Nextgen Healthcare (NXGN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 19.05% and 4.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?